Three subgroups have been identified among supratentorial tumors (ST-EPN): subependymomas; EPN, YAP1 fusion-positive; and EPN, ZFTA fusion-positive (as specified by the World Health Organization’s (WHO-2021) classification) [3, 24–26]. This evidence concerns the gene YAP1 and subependymoma.